A link between legalized marijuana and reduced opioid deaths
Opioid-related deaths decreased following the legalization of recreational marijuana in Colorado, according to a study led by a public health researcher from UNT Health Science Center.
The study, published in the American Journal of Public Health, showed a 6 percent reduction in opioid-related deaths in the two years after Colorado’s marijuana legalization, reversing the previous upward trend.
“As policy makers continue to grapple with both the growing opioid crisis and the rapidly changing landscape of marijuana laws in the U.S., scientific evidence is needed to help inform policy decisions to combat this disturbing upward trend in opioid-related deaths,” said Melvin D. Livingston, PhD, Assistant Professor at UNTHSC and lead author of the study.
Illegal and legally prescribed opioids now account for nearly 30,000 deaths a year in the United States, and the Centers for Disease Control and Prevention say that 91 Americans die every day from an opioid overdose. CDC data shows that opioid deaths from prescription drugs, heroin and synthetics like fentanyl have more than quadrupled since 1999.
In a July report to the White House, the U.S. Commission on Combating Drug Addiction and the Opioid Crisis emphasized the severity of the problem, calling America “a nation in crisis.”
The researchers analyzed Colorado data covering a 15-year period from 2000 to 2015 to compare changes in the number of opioid-related deaths before and after recreational marijuana sale and use was legalized.
“As of 2016, eight states and Washington DC have legalized recreational marijuana. While we found an apparent public health benefit in short-term reduction of opioid-related deaths following Colorado’s legalization, it’s important to note that expanded, legalized marijuana can also be associated with significant potential harms,” Dr. Livingston said.
“For policymakers to weigh decisions balancing potential beneficial and detrimental effects of these laws, researchers must continue to examine the full range of health outcomes through further study,” he said.
Co-authors of the study were Tracey E. Barnett, PhD, Associate Professor and Associate Dean for Academic Affairs at UNTHSC’s School of Public Health; Chris Delcher, PhD, from the University of Florida; and Alex C. Wagenaar, PhD, from Emory University.
By Sally Crocker When the U.S. Surgeon General published a recent health advisory– the first such alert in the last decade – asking for the public’s assistance in tackling the nation’s growing opioid epidemic, Dr. Scott Walters from the UNTHSC School of Public Health made plans to do his ...Read more
Sep 19, 2018
By Alex Branch University of North Texas quarterback Mason Fine faked a handoff and threw a perfect 60-yard touchdown pass to a streaking receiver, and the Mean Green sideline erupted. Players leaped off the bench, coaches pumped their fists and the cheerleaders hugged. Everyone inst...Read more
Sep 18, 2018
By Alex Branch A UNT Health Science Center professor is preparing physical students to provide innovative care that can improve the quality of life for the nearly 1 million Americans expected to have Parkinson’s disease by 2020. Howe Liu, PT, PhD, Professor of Physical Therapy, pa...Read more
Sep 17, 2018
By Jan Jarvis In 1998, a team of researchers that included Abe Clark, PhD, won worldwide recognition for its discovery of the first gene that causes glaucoma. Two decades later, the same team has found a possible treatment for this blinding eye disease. “We’ve gone from discov...Read more
Sep 13, 2018